Hinge Health Reduces Imaging Visits
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 24 2025
0mins
Should l Buy HNGE?
Source: Newsfilter
Hinge Health Inc announced a significant breakthrough in its chronic back pain program, showing a 60% reduction in imaging visits for participants compared to traditional physical therapy. This finding is based on a study utilizing data from over 100 million commercially insured lives in the U.S. from 2016 to 2021.
The reduction in unnecessary imaging not only lowers healthcare costs but also enhances patient care quality, emphasizing the effectiveness of digital musculoskeletal care. The study highlights the inappropriate use of imaging for low back pain, where many procedures are not clinically indicated.
Hinge Health's approach leverages an AI-powered care model and wearable devices, showcasing the potential of digital healthcare in improving patient outcomes and reducing expenses. This positive news likely contributed to the stock's rise, reflecting investor confidence in the company's innovative solutions.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HNGE?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HNGE
Wall Street analysts forecast HNGE stock price to rise
14 Analyst Rating
14 Buy
0 Hold
0 Sell
Strong Buy
Current: 41.470
Low
59.00
Averages
64.50
High
72.00
Current: 41.470
Low
59.00
Averages
64.50
High
72.00
About HNGE
Hinge Health, Inc. leverages software, including artificial intelligence (AI), to largely automate care for joint and muscle health. The Company has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. It offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Hinge Health Executive Sells 50,000 Shares
- Executive Stock Sale: On April 1, 2026, Hinge Health Director Gabriel M.I. Mecklenburg sold 50,000 Class A common shares for approximately $1.92 million, reflecting executive liquidity management amid market fluctuations.
- Ownership Change: Following this transaction, Mecklenburg's direct Class A common stock holdings dropped to zero; however, he retains 3,268,813 convertible Class B shares, ensuring ongoing indirect control and beneficial ownership.
- Trading Plan Context: This sale is part of a Rule 10b5-1 trading plan adopted by Mecklenburg on December 1, 2025, indicating a pre-established liquidity strategy rather than a discretionary action.
- Market Performance Analysis: Hinge Health's stock has risen 23% over the past year despite a 15% decline year-to-date; however, the company reported a 46% year-over-year revenue increase to $171 million in Q4, highlighting its growth potential in the health technology sector.
See More
Hinge Health Director Sells 50,000 Shares
- Share Sale Details: On April 1, 2026, Hinge Health Director Gabriel M.I. Mecklenburg sold 50,000 Class A common shares for approximately $1.92 million at a weighted average price of $38.46 per share, reducing his direct holdings to zero, indicating a potential lack of confidence in the company's future prospects.
- Market Performance Volatility: Hinge Health's stock experienced an 80% increase over the past year but has declined 15% year-to-date, reflecting broader market weaknesses despite the company's strong performance in the health technology sector.
- Financial Performance Highlights: In Q4 2026, Hinge Health reported a 46% year-over-year revenue increase to $171 million, with free cash flow rising 65% to $62 million, demonstrating ongoing efforts to expand its customer base and revenue, with total customers increasing by 25% to over 2,800.
- Valuation Attractiveness: As revenue grows, Hinge's price-to-sales (P/S) ratio has decreased from over 10x in September 2025 to the current 5.4x, indicating enhanced attractiveness as a growth stock, although it was not included in the analyst team's top investment picks.
See More
Hinge Health Expands Public Sector Services
- Service Expansion: Hinge Health is now delivering musculoskeletal (MSK) care to 24 state employee health plan clients, addressing the public sector's need for early intervention and accessibility, aimed at reducing healthcare costs while enhancing employee health.
- Coverage Reach: Currently, Hinge Health supports over 300 public sector organizations, reaching more than 5 million individuals across state and local governments, higher education, and public institutions, showcasing its extensive impact in the public health sector.
- Digital Care Model: By providing 24/7 access to care, Hinge Health's digital program adapts to various work roles and schedules, ensuring employees receive timely, high-quality care amidst their busy lives, thereby improving overall employee wellbeing.
- Strategic Partnerships: Hinge Health collaborates with forward-thinking organizations to deliver a higher standard of care that balances fiscal responsibility with employee health, redefining the care experience for public sector employees and their families.
See More
Hinge Health Appoints Tyler Sloat to Board
- New Board Member: Hinge Health has appointed Tyler Sloat, CFO and COO of Freshworks, to its board, bringing nearly three decades of operational leadership experience in high-growth tech companies, which will enhance the company's financial and operational management capabilities.
- Rich Operational Experience: Sloat oversees accounting, finance, IT, and corporate strategy at Freshworks, and previously served as CFO at Zuora, guiding the company from startup to its 2018 IPO, showcasing his leadership in rapid expansion phases.
- Tech-Healthcare Integration: Sloat noted that Hinge Health's platform combines cutting-edge technology with clinical rigor to address significant cost issues in healthcare, and his experience is expected to support the company's further development in healthcare automation.
- Future Outlook: Hinge Health focuses on improving treatment outcomes for musculoskeletal conditions through an AI-powered care model and wearable devices, and Sloat's addition is anticipated to advance the company's mission of enhancing member health outcomes and reducing costs for clients.
See More
Hinge Health (HNGE.US) Director Plans to Sell $11.46 Million in Common Stock via Form 144
- Stock Sale Announcement: Director Gabriel Mecklenburg plans to sell 250,000 shares of its common stock on March 6.
- Market Value: The total market value of the shares being sold is approximately $11.46 million.
See More
Insight Holdings Reduces AppFolio Stake Significantly
- Stake Reduction Impact: Insight Holdings Group reduced its AppFolio position by 108,050 shares in Q4 2025, resulting in a $31.70 million decline in value, indicating a waning confidence in the company's prospects within its overall asset allocation.
- Asset Allocation Shift: AppFolio's weighting in Insight Holdings' 13F assets dropped to 0.78% from 2.6% in the previous quarter, reflecting a broader trend of fund downsizing that may affect market attention towards AppFolio.
- Poor Market Performance: As of February 17, 2026, AppFolio shares were priced at $168.79, down 20.6% over the past year, significantly underperforming the S&P 500 by 34.25 percentage points, highlighting the cooling narratives in both real estate and high-multiple SaaS sectors.
- Business Model Challenges: AppFolio's revenue growth hinges on the number of units managed and the utilization of additional services; investors should monitor whether it can evolve into a financial backbone for clients, thereby increasing revenue per unit and enhancing competitive positioning.
See More
Hinge Health Executive Sells 50,000 Shares
- Executive Stock Sale: On April 1, 2026, Hinge Health Director Gabriel M.I. Mecklenburg sold 50,000 Class A common shares for approximately $1.92 million, reflecting executive liquidity management amid market fluctuations.
- Ownership Change: Following this transaction, Mecklenburg's direct Class A common stock holdings dropped to zero; however, he retains 3,268,813 convertible Class B shares, ensuring ongoing indirect control and beneficial ownership.
- Trading Plan Context: This sale is part of a Rule 10b5-1 trading plan adopted by Mecklenburg on December 1, 2025, indicating a pre-established liquidity strategy rather than a discretionary action.
- Market Performance Analysis: Hinge Health's stock has risen 23% over the past year despite a 15% decline year-to-date; however, the company reported a 46% year-over-year revenue increase to $171 million in Q4, highlighting its growth potential in the health technology sector.
See More
Hinge Health Director Sells 50,000 Shares
- Share Sale Details: On April 1, 2026, Hinge Health Director Gabriel M.I. Mecklenburg sold 50,000 Class A common shares for approximately $1.92 million at a weighted average price of $38.46 per share, reducing his direct holdings to zero, indicating a potential lack of confidence in the company's future prospects.
- Market Performance Volatility: Hinge Health's stock experienced an 80% increase over the past year but has declined 15% year-to-date, reflecting broader market weaknesses despite the company's strong performance in the health technology sector.
- Financial Performance Highlights: In Q4 2026, Hinge Health reported a 46% year-over-year revenue increase to $171 million, with free cash flow rising 65% to $62 million, demonstrating ongoing efforts to expand its customer base and revenue, with total customers increasing by 25% to over 2,800.
- Valuation Attractiveness: As revenue grows, Hinge's price-to-sales (P/S) ratio has decreased from over 10x in September 2025 to the current 5.4x, indicating enhanced attractiveness as a growth stock, although it was not included in the analyst team's top investment picks.
See More
Hinge Health Expands Public Sector Services
- Service Expansion: Hinge Health is now delivering musculoskeletal (MSK) care to 24 state employee health plan clients, addressing the public sector's need for early intervention and accessibility, aimed at reducing healthcare costs while enhancing employee health.
- Coverage Reach: Currently, Hinge Health supports over 300 public sector organizations, reaching more than 5 million individuals across state and local governments, higher education, and public institutions, showcasing its extensive impact in the public health sector.
- Digital Care Model: By providing 24/7 access to care, Hinge Health's digital program adapts to various work roles and schedules, ensuring employees receive timely, high-quality care amidst their busy lives, thereby improving overall employee wellbeing.
- Strategic Partnerships: Hinge Health collaborates with forward-thinking organizations to deliver a higher standard of care that balances fiscal responsibility with employee health, redefining the care experience for public sector employees and their families.
See More
Hinge Health Appoints Tyler Sloat to Board
- New Board Member: Hinge Health has appointed Tyler Sloat, CFO and COO of Freshworks, to its board, bringing nearly three decades of operational leadership experience in high-growth tech companies, which will enhance the company's financial and operational management capabilities.
- Rich Operational Experience: Sloat oversees accounting, finance, IT, and corporate strategy at Freshworks, and previously served as CFO at Zuora, guiding the company from startup to its 2018 IPO, showcasing his leadership in rapid expansion phases.
- Tech-Healthcare Integration: Sloat noted that Hinge Health's platform combines cutting-edge technology with clinical rigor to address significant cost issues in healthcare, and his experience is expected to support the company's further development in healthcare automation.
- Future Outlook: Hinge Health focuses on improving treatment outcomes for musculoskeletal conditions through an AI-powered care model and wearable devices, and Sloat's addition is anticipated to advance the company's mission of enhancing member health outcomes and reducing costs for clients.
See More
Hinge Health (HNGE.US) Director Plans to Sell $11.46 Million in Common Stock via Form 144
- Stock Sale Announcement: Director Gabriel Mecklenburg plans to sell 250,000 shares of its common stock on March 6.
- Market Value: The total market value of the shares being sold is approximately $11.46 million.
See More
Insight Holdings Reduces AppFolio Stake Significantly
- Stake Reduction Impact: Insight Holdings Group reduced its AppFolio position by 108,050 shares in Q4 2025, resulting in a $31.70 million decline in value, indicating a waning confidence in the company's prospects within its overall asset allocation.
- Asset Allocation Shift: AppFolio's weighting in Insight Holdings' 13F assets dropped to 0.78% from 2.6% in the previous quarter, reflecting a broader trend of fund downsizing that may affect market attention towards AppFolio.
- Poor Market Performance: As of February 17, 2026, AppFolio shares were priced at $168.79, down 20.6% over the past year, significantly underperforming the S&P 500 by 34.25 percentage points, highlighting the cooling narratives in both real estate and high-multiple SaaS sectors.
- Business Model Challenges: AppFolio's revenue growth hinges on the number of units managed and the utilization of additional services; investors should monitor whether it can evolve into a financial backbone for clients, thereby increasing revenue per unit and enhancing competitive positioning.
See More
